. Changesin the ratIo of retinol-ddretlnol in plasma of an adult who ingested 61 Amolof retinyl-d4acetate Plasmaspecimens were processed accordIngto the SPEprotocol described sented here represents a dramatic improvement over past methods. The elimination of HPLC would allow on-site sample preparation with a minimum of equipment and technical skill. This SPE protocol will be of particular value in epidemiological studies where laboratory facilities are not readily available. 
developed a sensitive, specific, and simple solid-phase competitive ELA for melatonin. In this assay, we coat a 96-well microtiter plate with specific anti-melatonin serum; the melatonin to be assayed competes with melatonin-Na--p-carboxybenzyl (3)-salksaline phosphatase (AP) conjugate. The analytical and physiological validations of this technique are described here.
MaterIals and Methods Sample Collection
Blood was sampled from three healthy subjects every 1-2 h during 24 h, and another 88 samples were obtained during the day and night from subjects with chronic insomnia. Blood samples were also taken from 2-month-old male and female Sprague-Dawley rats injected with saline or isoproterenol (ISO), an agonist of -adrenergic receptors. All samples were obtained without anticoagulant and centrifuged; serum was removed and stored at -20 #{176}C until assay.
Reagents
The coating buffer was NaHCO3 (0.05 mol/L) and Na2CO3 (0.05 mol/L), pH 9.6. Assay buffer contained 0.05 mol each of phosphates (Na2HPO4 and NaH2PO4), 0.15 mol of NaC1, and 1 g of gelatin per liter (pH 7. The specific anti-melatonin serum used in this study (ClDtech Research Inc., Mississauga, Canada) was produced by immunizing sheep with melatonin coupled to bovine serum albumin (BSA) (4). The procedure for the antiserum production was described previously (1).
Melatonin-Na-p-carboxybenzyl was conjugated with AP (Helix Biotech Corp., Richmond, Canada). The conjugate is stable for at least 2 years when stored at -70#{176}C; a working solution was stored at 4#{176}C for 2 months without loss of enzymatic or immunological activity.
Apparatus
The solid-phase EJA was performed with microtiter plates (MAXISORP; GIBCO, Burlington, Canada) and a microtiter plate spectrophotometer The CVs for the bouncl/ unbound melatonin (B/B0) ratio for each standard ranged from 4.0% to 14.4%, indicating that the precision and stability of the standard curves were satisfactory. The lowest detectable concentration of melatonin, defined as the amount of melatornn producing a displacement of 2 SD from B0, was 1.0 fmol/well. An alternative indication of the sensitivity of the assay is the standard concentration equivalent to a B/B0 value of 50%, which was 15.11 fmol/well in this assay.
Pooled human serum extracts collected during the night and serially diluted with the assay buffer gave displacement parallel to that of the melatonin standard curve when up to 200 &L of serum extracts was assayed. To ascertain analytical recovery from extracts, we added three known amounts of melatonin to serum extract pools (120.5, 291.9, and 563.9 pmol/L) and then assayed the pools. Mean analytical recovery of melatonm from these serum extracts was 99.4% (SD 8.4%, range 92.7-108.9%, n = 9).
The intra-and interassay CVs were determined by including, in duplicate, two IQC samples containing different melatonin concentrations in 10 runs (5 A good correlation was obtained between the two methods (r = 0.88): y = 0.62x -0.76, S,, = 0.03 (Figure 2) .
Physiological and Animal Studies
The concentrations of melatonin from three subjects measured over a 24-h period are shown in Figure 3 . A typical pattern obtained for the subjects showed lowest concentrations during the day between 0900 and 2100 and high concentrations at night between 2200 and 0600.
Melatonin concentrations in serum and pineal homogenates of 2-month-old male and female rats after injection parenterally with saline or ISO are presented in Table 2 for human serum melatonin and rat serum and pineal melatonin responses to ISO or saline injection were similar to published data (6, 7, 9). Thus, the results strongly support the validity of the present assay. The high specificity and affinity of the antiserum used may be primarily responsible for these characteristics of the assay. The main advantage of this assay is that the melatonin-p-carboxybenzyl-AP conjugate is stable, is more convenient than 3H or 125!, and presents no problem with disposal of radioactive waste. Other advantages are the requirement of only a small serum sample-0.l mL vs 0.5 mL of serum for the R!A-and the ability to measure melatonin in rat serum without prior extraction with organic solvent. The use of microtiter plates eliminates the need for centrifugation. 
